I asked a friend of mine (medical doctor) what she thinks of...

I asked a friend of mine (medical doctor) what she thinks of Fillerina, and she hadn't known what it is. I told her that it is a cosmetic filler. Let me share her thoughts about the selling point for those in general. (I would think some of this also applies to évolis - "when people get positive results they will keep on buying".)



I told her it doesn't get injected but instead applied onto the skin, and she liked that. A lot.

She also said this about people purchasing cosmetics:

Based on her opinion alone, my bet is that Fillerina is a very easy, cost-effective revenue booster for the next three years or beyond, and it will show synergetic effects for évolis.

I do hope that évolis will significantly benefit from the co-marketing initiative in particular. I think management is pulling all strings to get people to know about évolis in a not only cost effective, but even revenue generating way.

It could turn out to be just as brilliant a strategy and growth hack as limiting research expenditure through collaborations, as mentioned by Maria Halasz in the PI video.